首页> 外文期刊>Molecular Genetics and Metabolism Reports >Impact of chemical modification of sulfamidase on distribution to brain interstitial fluid and to CSF after an intravenous administration in awake, freely-moving rats
【24h】

Impact of chemical modification of sulfamidase on distribution to brain interstitial fluid and to CSF after an intravenous administration in awake, freely-moving rats

机译:硫酰胺酶化学改性对脑间质液和静脉内施用后静脉内施用后CSF的影响,自由移动大鼠

获取原文
           

摘要

Mucopolysaccharidosis III A (MPS IIIA) is an autosomal recessive lysosomal storage disorder caused by deficiency of the enzyme sulfamidase. The disorder results in accumulation of heparan sulfate, lysosomal enlargement and cellular and organ dysfunction. Patients exhibit progressive neurodegeneration and behavioral problems and no treatment is currently available. Enzyme replacement therapy is explored as potential treatment strategy for MPS IIIA patients and to modify the disease, sulfamidase must reach the brain. The glycans of recombinant human sulfamidase (rhSulfamidase) can be chemically modified to generate CM-rhSulfamidase. The chemical modification reduced the affinity to the cation-independent mannose-6-phosphate receptor with the aim a prolonged higher concentration in circulation and thus at the blood brain barrier. The pharmacokinetic properties in serum and the distribution to brain and to cerebrospinal fluid (CSF) of chemically modified recombinant human sulfamidase (CM-rhSulfamidase) were studied and compared to those of rhSulfamidase, after a single intravenous (i.v.) 30?mg/kg dose in awake, freely-moving male Sprague Dawley rats. Distribution to brain was studied by microdialysis of the interstitial fluid in prefrontal cortex and by repeated intra-individual CSF sampling from the cisterna magna. Push-pull microdialysis facilitated sampling of brain interstitial fluid to determine large molecule concentrations in awake, freely-moving male Sprague Dawley rats. Together with repeated serum and CSF sampling, push-pull microdialysis facilitated determination of CM-rhSulfamidase and rhSulfamidase kinetics after i.v. administration by non-compartments analysis and by a population modelling approach. Chemical modification increased the area under the concentration versus time in serum, CSF and brain interstitial fluid at least 7-fold. The results and the outcome of a population modelling approach of the concentration versus time data indicated that both compounds pass the BBB with an equilibrium established fairly rapid after administration. We suggest that prolonged high serum concentrations facilitated high brain interstitial fluid concentrations, which could be favorable to reach various target cells in the brain.
机译:粘多糖尿病III A(MPS IIIA)是由酶磺胺酶缺乏引起的常染色体隐性溶酶体储存障碍。该疾病导致硫酸乙酰肝素,溶酶体扩大和细胞和器官功能障碍的积累。患者表现出渐进式神经变性和行为问题,目前没有治疗。酶替代疗法被探索为MPS IIIA患者的潜在治疗策略并改变疾病,硫氨酸酶必须到达大脑。可以在化学修饰中重组人硫氨酸酶(rhsulfamid酶)的聚糖以产生cm-rhsulfamid酶。化学改性将与阳离子甘露糖-6-磷酸受体的亲和力降低了循环中延长较高浓度,从而在血脑屏障中延长。研究了在单个静脉内(IV)30?Mg / kg剂量的情况下研究了化学改性重组人氨基氨基酯酶(CM- rhsulfamid酶)和脑和脑脊髓液(CSF)的脑和脑脊髓液(CSF)的分布和脑脊液(CSF)。在清醒中,自由移动的男性Sprague Dawley大鼠。通过前额叶皮质中的间质液体的微透析和通过从Cisterna Magna进行重复的单独的CSF采样来研究对大脑的分布。推拉微透视促进脑间质液的取样,以确定唤醒的大分子浓度,可自由移动的雄性枝德利大鼠。与重复的血清和CSF采样一起,在I.V之后,推拉微透视促进CM-rhsulfaidase和rhsulfamidase动力学的测定。非隔室分析和人口建模方法管理。化学改性在血清,CSF和脑间质液中的浓度与时间下的区域增加了至少7倍。浓度与时间数据的群体建模方法的结果和结果表明,两种化合物在给药后通过平衡建立平衡。我们建议延长的高血清浓度促进高脑式间质性液体浓度,这可能有利于达到大脑中的各种靶细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号